Screener
Visteon VC Balance Sheet Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $464M-39.3% | $650M-3.1% | $682M+3.6% | $773M+23.5% | $765M+38.3% | ||
| $696M+21.3% | $666M+7.2% | $675M+10.1% | $613M+6.1% | $574M-20.2% | ||
| $359M+14.7% | $328M+10.8% | $316M+1.9% | $269M-4.9% | $313M-2.5% | ||
| $1.7B-4.7% | $1.8B+4.6% | $1.82B+7.3% | $1.79B+11.8% | $1.78B+4.5% | ||
| $557M+13.9% | $524M+8.0% | $516M+11.7% | $524M+15.9% | $489M+11.6% | ||
| $239M+724% | $233M+652% | $216M+535% | $222M+46.1% | $29M-17.1% | ||
| —— | $101M-8.2% | $105M+43.8% | $109M+53.5% | $112M+47.4% | ||
| —— | $65M+32.7% | $35M+16.7% | —— | $83M-32.0% | ||
| $3.4B+3.1% | $3.46B+4.6% | $3.42B+10.3% | $3.39B+14.2% | $3.3B+10.2% | ||
| $640M+20.1% | $620M+11.3% | $613M+10.3% | $540M+6.9% | $533M-2.6% | ||
| —— | $76M+744% | $34M+278% | $32M+167% | $9M-18.2% | ||
| $23M+27.8% | $15M-16.7% | $18M0.0% | $18M0.0% | $18M0.0% | ||
| $1.06B+12.2% | $1.02B+10.2% | $1.05B+13.6% | $992M+8.3% | $941M+0.4% | ||
| $307M+6.6% | $284M-2.7% | $279M-6.1% | $283M-6.0% | $288M-5.9% | ||
| 1M-99.6% | 250M0.0% | 250M0.0% | 1M0.0% | 250M0.0% | ||
| $2.89B+4.4% | $2.9B+3.8% | $2.86B+5.1% | $2.84B+7.0% | $2.77B+9.7% | ||
| $1.41B-7.5% | $1.61B+5.0% | $1.56B+9.7% | $1.57B+17.6% | $1.53B+18.7% | ||
| $3.4B+3.1% | $3.46B+4.6% | $3.42B+10.3% | $3.39B+14.2% | $3.3B+10.2% |
FAQ
- What are Visteon's total assets?
- Visteon (VC) holds $3.4B in total assets, up 3.1% year over year.
- How much debt does Visteon have?
- Visteon carries $459.0M in total debt against $1.4B of shareholders' equity, a debt-to-equity ratio of 0.32.
- How much cash does Visteon have?
- Visteon holds $464.0M in cash and equivalents.
- Can Visteon cover its short-term obligations?
- Its current ratio is 1.61 — current assets exceed current liabilities.
- Where does Visteon's balance sheet data come from?
- Every line is extracted from Visteon's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
